Neoflavon (Diosmin, Hesperidin)

Diosmin, the active ingredient in Neoflavon, is a flavonoid presented as an oral tablet for oral use. It treats chronic venous insufficiency, hemorrhoids and varicose veins in adult patients. GNH USA supplies Neoflavon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neoflavon, a flavonoid venotonic, is used in conditions affecting venous circulation.

Chronic venous insufficiency: improves venous return and reduces leg swelling. Hemorrhoids: alleviates swelling and discomfort of hemorrhoidal tissue. Varicose veins: reduces vein distension and associated pain.

Neoflavon is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or mild vomiting - Abdominal pain or cramps - Headache - Dizziness or light‑headedness - Transient skin rash or pruritus

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis - Severe thrombocytopenia or bleeding disorders - Hepatic dysfunction or elevated liver enzymes - Acute hypotension - Severe skin reactions such as Stevens‑Johnson syndrome - Unexplained fever or systemic inflammatory response

Before using Neoflavon, consider the following safety measures. - Age restriction: use in adults only; safety in children not established. - Pregnancy: safety category unknown; avoid unless clearly needed. - Breastfeeding: caution advised; consult a healthcare professional. - Concomitant anticoagulant or antiplatelet therapy may increase bleeding risk. - Known hypersensitivity to flavonoids: discontinue use. - Store at ambient temperature: keep in the original pack, protect from moisture.

Neoflavon may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Antiplatelet agents (e.g., clopidogrel): additive antithrombotic effect. - Strong CYP3A4 inhibitors: may raise plasma levels of flavonoids.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for additive gastrointestinal irritation. - Diuretics: possible electrolyte disturbances. - Corticosteroids: may enhance fluid retention and edema.